Diagnostic exome sequencing in early‐onset Parkinson's disease confirms VPS13C as a rare cause of autosomal‐recessive Parkinson's disease
Open accessThe DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Abstract
Parkinson's disease (PD) is a genetically heterogeneous disorder and new putative disease genes are discovered constantly. Therefore, whole‐exome sequencing could be an efficient approach to genetic testing in PD. To evaluate its performance in early‐onset sporadic PD, we performed diagnostic exome sequencing in 80 individuals with manifestation of PD symptoms at age 40 or earlier and a negative family history of PD. Variants in validated and candidate disease genes and risk factors for PD and atypical Parkinson syndromes were annotated, followed by further analysis for selected variants. We detected pathogenic variants in Mendelian genes in 6.25% of cases and high‐impact risk factor variants in GBA in 5% of cases, resulting in overall maximum diagnostic yield of 11.25%. One individual was compound heterozygous for variants affecting canonical splice sites in VPS13C, confirming the causal role of protein‐truncating variants in this gene linked to autosomal‐recessive early‐onset PD. Despite the low diagnostic yield of exome sequencing in sporadic early‐onset PD, the confirmation of the recently discovered VPS13C gene highlights its advantage over using predefined gene panels.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Richards, S., Aziz, N., Bale, S., Bick, D., Das, S., Gastier-Foster, J., Grody, W. W., Hegde, M., Lyon, E., Spector, E., et al. (2015) · Genetics in Medicine · doi:10.1038/gim.2015.30 · Cited by 32,594
The prevalence of Parkinson's disease: a systematic review and meta-analysis
Pringsheim, T., Jette, N., Frolkis, A., & Steeves, T. D. L. (2014) · Movement Disorders · doi:10.1002/mds.25945 · Cited by 2,188
Multicenter Analysis of Glucocerebrosidase Mutations in Parkinson's Disease
Sidransky, E., Nalls, M. A., Aasly, J. O., Aharon-Peretz, J., Annesi, G., Barbosa, E. R., Bar-Shira, A., Berg, D., Bras, J., Brice, A., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0901281 · Cited by 2,135
Genetics in Parkinson disease: Mendelian versus non‐Mendelian inheritance
Hernandez, D. G., Reed, X., & Singleton, A. B. (2016) · Journal of Neurochemistry · doi:10.1111/jnc.13593 · Cited by 448 · cited 2×
“Targeted sequencing studies have reported an increased frequency of carriers of heterozygous variants in PARK2 in PD patients compared to healthy controls.(31) This is in contrast to results of larger case–control sequencing efforts which did not detect an enrichment of such variants in PD patients.”
BackgroundResultProgress in unraveling the genetic etiology of Parkinson disease in a genomic era
Verstraeten, A., Theuns, J., & Van Broeckhoven, C. (2015) · Trends in Genetics · doi:10.1016/j.tig.2015.01.004 · Cited by 226 · cited 2×
“There is considerable genetic heterogeneity in PD with to date 11 confirmed genes with Mendelian inheritance and several putative Mendelian genes and risk factors for which either conflicting evidence exists or no replication in independent datasets has been reported yet.(3,4) The strongest genetic risk factors for PD…”
Background
Cited by
Mutations in VPS13D lead to a new recessive ataxia with spasticity and mitochondrial defects
Seong, E., Insolera, R., Dulovic, M., Kamsteeg, E., Trinh, J., Brüggemann, N., Sandford, E., Li, S., Ozel, A. B., Li, J. Z., et al. (2018) · Annals of Neurology · doi:10.1002/ana.25220 · Cited by 163
Role of VPS13, a protein with similarity to ATG2, in physiology and disease
Ugur, B., Hancock-Cerutti, W., Leonzino, M., & De Camilli, P. (2020) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2020.05.027 · Cited by 73
VPS13B is localized at the interface between Golgi cisternae and is a functional partner of FAM177A1
Ugur, B., Schueder, F., Shin, J., Hanna, M. G., Wu, Y., Leonzino, M., Su, M., McAdow, A. R., Wilson, C., Postlethwait, J., et al. (2024) · Journal of Cell Biology · doi:10.1083/jcb.202311189 · Cited by 18
“…et al., 2001), Cohen syndrome (VPS13B) (Kolehmainen et al., 2003), Parkinson ’ s disease (VPS13C) (Lesage et al., 2016; Darvish et al., 2018; Schormair et al., 2018), and several neurological disorders or embryonic lethality in the case of complete loss-of-function (VPS13D) (Gauthier et…”
Metadata
- Authors
- Schormair, B., Kemlink, D., Mollenhauer, B., Fiala, O., Machetanz, G., Roth, J., Berutti, R., Strom, T. M., Haslinger, B., Trenkwalder, C., Zahorakova, D., Martasek, P., Ruzicka, E., & Winkelmann, J.
- Venue
- Clinical Genetics
- Publisher
- Wiley
- Published
- 2018-01-24
- Volume
- 93
- Issue
- 3
- Pages
- 603-612
- ISSN
- 0009-9163 (ISSN-L)
- 1399-0004
- OpenAlex
- W2751340431
- Cited by
- 92
- References
- 5
- FWCI
- 5.37
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.